D&D Pharmatech is expected to file its 2026 first-half report by August 14, 2026, providing updated financial results, cash position, and pipeline-development disclosures.
Korean translation
디앤디파마텍은 2026년 8월 14일까지 반기보고서를 제출할 예정이며, 최신 실적·현금보유액·파이프라인 진행 현황이 공개될 전망임.